Lovastatin was identified through virtual screening as a potential inhibitor of the LEDGF/p75-HIV-1 integrase interaction. In an AlphaScreen assay, lovastatin inhibited the purified recombinant protein-protein interaction (IC50 = 1.97 ± 0.45 μm) more effectively than seven other tested statins. None of the eight statins, however, yielded antiviral activity in vitro, while only pravastatin lactone yielded detectable inhibition of HIV-1 integrase strand transfer activity (31.65% at 100 μm). A correlation between lipophilicity and increased cellular toxicity of the statins was observed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/cbdd.12384 | DOI Listing |
Publication Analysis
Top Keywords
ledgf/p75-hiv-1 integrase
8
integrase interaction
8
evaluation statins
4
statins potential
4
potential inhibitors
4
inhibitors ledgf/p75-hiv-1
4
interaction lovastatin
4
lovastatin identified
4
identified virtual
4
virtual screening
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!